China is investing heavily in cutting-edge genetic experiments. It’s part of their quest to become a biotech superpower.
On today’s Big Take Asia Podcast, host K. Oanh Ha, Bloomberg’s Karoline Kan and Oxford University geneticist Andy Greenfield discuss China’s pharmaceutical ambitions and the loose regulatory environment that allows the animal testing industry to thrive.
Read more: China Pushes Boundaries With Animal Testing to Win Global Biotech Race

The Strait of Hormuz Is Open. Now What?
15:46

Iran and Global Debt Cloud IMF-World Bank Meetings
19:29

The Winners and Losers of Trump’s Tax Policy
15:24